mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 26.2% | 112.9 / 44.7 | 65 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 26.1% | 615.5 / 222.4 | 399 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 25.4% | 99.5 / 39.1 | 69 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 23.1% | 121.3 / 27.0 | 65 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| Marginal new junction evidence (lowest skew 10 of 82 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | 4274731 = | 296 (6.650) | 10 (0.240) | 9/266 | 3.5 | 3.4% | intergenic (+69/+30) | ssb/yjcB | single‑stranded DNA‑binding protein/putative inner membrane protein |
| ? | NC_000913_3_bme_pgi | 4274756 = | 285 (6.890) | intergenic (+94/+5) | ssb/yjcB | single‑stranded DNA‑binding protein/putative inner membrane protein | |||||
| * | ? | NC_000913_3_bme_pgi | 4245134 = | NA (NA) | 11 (0.260) | 9/272 | 3.6 | 2.8% | noncoding (42/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 4262250 | 305 (6.850) | 8 (0.190) | 8/270 | 3.9 | 2.7% | coding (581/1038 nt) | dusA | tRNA‑dihydrouridine synthase A |
| ? | NC_000913_3_bme_pgi | = 4262256 | 280 (6.660) | coding (587/1038 nt) | dusA | tRNA‑dihydrouridine synthase A | |||||
| * | ? | NC_000913_3_bme_pgi | 4542683 = | 24 (0.540) | 8 (0.190) | 7/268 | 4.2 | 27.4% | intergenic (+49/‑433) | fimE/fimA | tyrosine recombinase/inversion of on/off regulator of fimA/major type 1 subunit fimbrin (pilin) |
| ? | NC_000913_3_bme_pgi | 4542997 = | 20 (0.480) | intergenic (+363/‑119) | fimE/fimA | tyrosine recombinase/inversion of on/off regulator of fimA/major type 1 subunit fimbrin (pilin) | |||||
| * | ? | NC_000913_3_bme_pgi | = 4236226 | 374 (8.400) | 8 (0.190) | 7/266 | 4.2 | 2.2% | intergenic (+77/‑37) | yjbE/yjbF | extracellular polysaccharide production threonine‑rich protein/extracellular polysaccharide production lipoprotein |
| ? | NC_000913_3_bme_pgi | = 4236230 | 355 (8.580) | intergenic (+81/‑33) | yjbE/yjbF | extracellular polysaccharide production threonine‑rich protein/extracellular polysaccharide production lipoprotein | |||||
| * | ? | NC_000913_3_bme_pgi | 3708322 = | NA (NA) | 9 (0.210) | 7/272 | 4.3 | 2.3% | noncoding (51/86 nt) | REP267 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP267 (repetitive extragenic palindromic) element; contains 2 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | 2118562 = | 50 (1.120) | 9 (0.210) | 7/272 | 4.3 | 4.0% | noncoding (97/186 nt) | REP144 (repetitive extragenic palindromic) element; contains 4 REP sequences | REP144 (repetitive extragenic palindromic) element; contains 4 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | 2118466 = | NA (NA) | 9 (0.210) | 7/272 | 4.3 | 2.3% | noncoding (1/186 nt) | REP144 (repetitive extragenic palindromic) element; contains 4 REP sequences | REP144 (repetitive extragenic palindromic) element; contains 4 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | 762803 = | NA (NA) | 9 (0.210) | 7/272 | 4.3 | 2.3% | noncoding (42/167 nt) | REP68 (repetitive extragenic palindromic) element; contains 4 REP sequences | REP68 (repetitive extragenic palindromic) element; contains 4 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | 354734 = | 37 (0.830) | 9 (0.210) | 7/272 | 4.3 | 4.1% | noncoding (136/171 nt) | REP26 (repetitive extragenic palindromic) element; contains 4 REP sequences | REP26 (repetitive extragenic palindromic) element; contains 4 REP sequences |
| ? | NC_000913_3_bme_pgi | 4245166 = | 387 (9.140) | noncoding (74/126 nt) | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | REP315 (repetitive extragenic palindromic) element; contains 3 REP sequences | |||||